Harmony Biosciences To Participate In Two Investor Conferences In November

News provided by

Nov 11, 2021, 08:05 ET

PLYMOUTH MEETING, Pa., Nov. 11, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that Harmony's President and CEO, John C. Jacobs, will participate in fireside chats and host investor meetings at the following upcoming virtual conferences:

Jefferies London Healthcare Conference

Fireside Chat: A pre-recorded fireside chat will be available on-demand beginning on Thursday, November 18 at 8:00am GMT / 3:00am ET through Friday, November 19 at 5:00pm GMT / 12:00pm ET
1x1 Meetings: Thursday, November 18, 2021 and Friday, November 19, 2021

Piper Sandler 33rd Annual Virtual Healthcare Conference

Fireside Chat: A pre-recorded fireside chat will be available on-demand beginning on Monday, November 22^nd at 10:00am ET
1x1 Meetings: Tuesday, November 30, 2021

The audio webcast of the fireside chats will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.

About Harmony Biosciences
Harmony Biosciences is a commercial stage pharmaceutical company headquartered in Plymouth Meeting, PA. The Company was established by Paragon Biosciences, LLC, and is focused on providing novel treatment options for people living with rare neurological diseases who have unmet medical needs. For more information on Harmony, please visit the company's website: www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:
Patti Bank
ICR Westwicke
415-513-1284
[email protected]

Harmony Biosciences Media Contact:
Nancy Leone
215-891-6046
[email protected]

SOURCE Harmony Biosciences